Introduction
The Female Athlete Triad was first described in 1992 as a syndrome seen in female athletes consisting of disordered eating, amenorrhea, and osteoporosis. Current understanding has expanded to include a spectrum of three components:°l ow energy availability (EA) with or without disordered eating/eating disorder°m enstrual irregularities°l ow bone mineral density (BMD) (1, 3, 4) Low EA (1, 2) Y Energy expenditure (kcal) = metabolic equivalent of a task Â weight (kg) Â duration of activity (h) Y Daily EA = energy intake (kcal) j energy expenditure (kcal)/fat free mass or lean body mass (kg) Y Low EA: G30 kcalIkg j1 fat-free mass (FFM) per day Y Optimal EA: 45 kcalIkg j1 FFM per day Y Low body mass index: G17.5 kgIm j2 or G85% of the expected body weight
Menstrual irregularity (2,4) Y Primary amenorrhea: absence of menarche by the age of 15 years Y Secondary amenorrhea: absence of three consecutive menstrual cycles in a previously menstruating woman Y Oligomenorrhea: cycle length 935 d or G9 cycles per year Low BMD (1) Y Low BMD: Z-score less than j1.0 in female athletes in weight bearing sports Y Osteoporosis: Z-score j2.0 or less with one or more secondary risk factors for the fracture Other Populations (2) Y Most data are from Caucasian women, but nonwhite and male athletes are susceptible to the same consequences from chronic low energy availability. Y African-American women have a lower risk of eating disorders, low BMD, and pathologic fractures compared with Caucasian women but can still experience the Triad. Y Male athletes are at lower risk of eating disorders and poor bone health than female athletes.°F unctional suppression of the hypothalamic pituitary axis results in testosterone suppression, which has a negative impact on bone health.°M ale runners and cyclists may be at higher risk of low BMD than other athletes.
Treatment (1, 2, 4) Y The goal of treatment is to increase EA utilizing a multidisciplinary team, which may include a sports physician, nutritionist, psychologist, therapist/athletic trainer, and physiologist. Y Energy intake should be increased by 300 to 600 kcalId j1 . Y Consider decreasing exercise in combination with increasing dietary intake. Y Athletes with DE/ED should be treated by a mental health professional who has experience with athletes. Y Oral contraceptives have not been shown to improve BMD independent of an increase in EA and are not recommended as a primary treatment for the Triad. Y Athletes with low BMD should participate in 2 to 3 dIwk j1 of high-impact loading and resistance training. Y Calcium intake of 1,000 to 1,500 mgId j1 is recommended. Y Vitamin D 25, OH levels should be 32 to 50 ngImL j1 with 1,500 to 2,000 IUId j1 of vitamin D intake. Y Bisphosphonates, parathyroid hormone peptides, and calcitonin are not approved for premenopausal women. Y An individual's prognosis depends largely on early identification and intervention.
